Wegovy is a weekly injection containing semaglutide, designed to support weight loss in women who are overweight or obese, including those going through menopause. It is intended for adults with a BMI of ≥30, or ≥27 if accompanied by weight-related conditions such as high blood pressure, elevated cholesterol, or type 2 diabetes.
Semaglutide works by activating the GLP-1 receptor, which helps to reduce hunger and promotes a feeling of fullness more quickly. Wegovy should always be used in conjunction with healthy eating and regular exercise. This medication is available by prescription only. Read here to learn more about how this weight loss treatment may support you during menopause if losing weight has been particularly challenging.











